Comparison of baseline characteristics and CMV IgG seropositivity between MF/SS and non-MF/SS patients
. | MF/SS . | Non-MF/SS . | P . |
---|---|---|---|
No. patients | 53 | 26 | |
No. female (%) | 27 (51.0) | 15 (57.7) | .57 |
Median age, y | 58 | 47 | .27* |
Race, no. (%) | |||
White | 35 (66.0) | 16 (61.5) | .69 |
Black Afro-Caribbean | 9 (17.0) | 5 (19.2) | >.999 |
South/southeast Asian | 3 (5.7) | 2 (7.7) | >.999 |
Ethnic origin not known | 6 (11.3) | 3 (11.5) | >.999 |
Automated CMV IgG+, no. (%) | 32 (60.4) | 16 (61.5) | .92 |
Median automated value (IQR) | 117 (2.2-249) | 137 (2.5-250) | .88* |
Manual CMV IgG+, no. (%) | 31 (58.4) | 15 (57.7) | .95 |
. | MF/SS . | Non-MF/SS . | P . |
---|---|---|---|
No. patients | 53 | 26 | |
No. female (%) | 27 (51.0) | 15 (57.7) | .57 |
Median age, y | 58 | 47 | .27* |
Race, no. (%) | |||
White | 35 (66.0) | 16 (61.5) | .69 |
Black Afro-Caribbean | 9 (17.0) | 5 (19.2) | >.999 |
South/southeast Asian | 3 (5.7) | 2 (7.7) | >.999 |
Ethnic origin not known | 6 (11.3) | 3 (11.5) | >.999 |
Automated CMV IgG+, no. (%) | 32 (60.4) | 16 (61.5) | .92 |
Median automated value (IQR) | 117 (2.2-249) | 137 (2.5-250) | .88* |
Manual CMV IgG+, no. (%) | 31 (58.4) | 15 (57.7) | .95 |
All P values were not significant.
IQR indicates interquartile range.
Unpaired t test. The χ2 or Fisher exact test was used for all other comparisons